Melanoma CME
ARTICLECME

Predictive biomarkers for immunotherapy: Where are we?

Author(s)/Faculty: Jeffrey Weber, MD, PhD
Release Date: 1/28/2016Expiration Date: 1/12/2019
Credit Type: CMENumber of Credits: 0.25
Content Type: ArticleProvider:
The identification of a robust and reproducible biomarker, which can be used to predict a favorable response to immunotherapy, or identify those patients who would have virtually no chance to respond to treatment, is an important focus of immunotherapy research. This CME activity will review the role of predictive biomarkers for melanoma treatment.